A NEW AND SAFE PHARMACEUTICAL PREPARATION FOR PROPHYLAXIS AND TREATMENT OF RESPIRATORY VIRAL INFECTIONS, ESPECIALLY CORONA VIRUSES

Coronaviruses are a group of enveloped viruses with single strand RNA. Among this group of viruses is COVID-19 which causes a novel coronavirus-infected pneumonia. The disease has a rapid progression between people. Infected people suffer from fever, generalized pain, dry cough, GIT disturbance and in severe cases will cause death. Till now there is no effective and approved treatment for COVID-19. A novel synergistic mixture comprising a combination of natural dried powder of medicinal plants or their extracts well mixed with bee honey contains important minerals. This mixture used for treatment and prevention of viral infections especially COVID-19. And also could be used as anti-oxidant, immunostimulant, anti-diabetic, anti-diarrhea, anti-hyperlipidemic, anti-pyretic, and anti-cancer..

Medienart:

Patent

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Europäisches Patentamt - (2021) vom: 30. Dez. Zur Gesamtaufnahme - year:2021

Sprache:

Englisch

Beteiligte Personen:

KHALIL IBRAHIM TAHA IBRAHIM [VerfasserIn]
ABD EL-LATIF SHAABAN ABD EL-AZIZ MASOUD [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

615
A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d)
A61P: Specific therapeutic activity of chemical compounds or medicinal preparations
Che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2021-12-30, Last update posted on www.tib.eu: 2022-08-29, Last updated: 2023-02-09

Patentnummer:

WO2021259441

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA013282808